CGT Industrial Upgrading Roadshow Series – Stop 4: Suzhou BioBAY!

Event Time：January 24, 2024 (Wednesday) 13:30

Event Venue：Room 201, Building B6, Phase I, BioBAY, No. 218 Xinghu Street, Suzhou Industrial Park, Suzhou City, Jiangsu Province

Organizer：Healthcare Innovative Ecosystem Alliance (HIEA)

Co-organizers：Xingcheng Biotechnology, Yeasen, LePure, Austar Group, VectorBuilder, Life Biosciences, Legend Capital

Organizer：VBHealth

Supporting Organizations：BioBAY、BioTOP

In November 2023, VCBeat New Medicine, in collaboration with enterprises across the CGT industry chain, hosted a series of “CGT Industry Upgrade Park Tour” events at two parks in Shanghai: Zhangjiang and Free Trade Zone No. 1. The events brought together decision-makers from innovative CGT companies and service providers across the industry chain on the same stage to voice their needs, share candid insights, and foster communication, networking, and co-creation of high-quality products.

Recently, the U.S. FDA has placed extreme emphasis on Chemistry, Manufacturing, and Controls (CMC) issues related to cell therapy products, to the extent that it has impacted the progress of clinical trials; therefore, CMC concerns cannot be overlooked. Additionally, as the capital winter has yet to abate, securing financing, expanding overseas, and ensuring survival have become challenges that all innovative enterprises must confront.

Based on this, byHosted by the Healthcare Innovative Ecosystem Alliance (HIEA), co-hosted by Hangzhou Xingcheng Biotechnology, Yeasen, LePure, Austar Group, VectorBuilder, and Life Biosciences, in partnership with Legend Capital, organized by VCBeat New Medicine, and supported by BioBAY and BioTOP, the fourth stop of the “CGT Industry Upgrade Series · Park Tour” themed “Go Further Without the Rat Race” will be held at Suzhou BioBAY on January 24 (Wednesday).

CGT from an Investment Perspective：Investment and Financing Strategies for Innovative Drugs from an Investment Perspective: Providing Development Recommendations for Innovative Pharmaceutical Companies

Optimal Supply Chain Solutions：Listening to Party A's needs, supply chain enterprises work together to explore the most suitable solutions, striving to help innovative companies transition smoothly, rapidly, and cost-effectively from IND to BLA.

Practical Insights on Global Expansion Strategies：More Specific Opportunities for Southeast Asian Market Expansion: Drug Registration and Filing in Islamic Regions, Offering Valuable Insights for All Enterprises Preparing to Go Global.

The “Suzhou BioBAY Tour” marks the fourth stop in the Park Tour series. Similar events will be held in other industrial parks in the future to promote the continuous upgrading and development of the CGT industry. We look forward to engaging in discussions and fostering mutual progress with industry peers, helping the CGT sector go further!

■ 13:30–13:35 Opening Remarks by the Moderator + Introduction to the Ecosystem

Moderator | Event Expectations and Ecosystem Synergy

■ 13:35–13:40 Opening Remarks by Park Leadership

■ 13：40-14：00

Keynote Speech 1 |Themed Sharing by the Rotating Co-Organizer

■ 14：00-15：10

Panel 1 | How to Join Forces to Help CGT Companies Navigate from IND to BLA with Stability, Speed, and Cost-Efficiency?

• Introduction to Core Competencies and Service Value

• How to Engage Constructively with Clients and Foster Mutual Support

■ 15：10-16：10

Panel 2 | Discussing Industrial Upgrading: Key CMC Points and Solutions for Gene and Cell Therapies

• No Generic Discussion of Regulations

• Discussion on Quality Control Strategies and Specific Service Cases

• Party A States Its Needs, Party B Presents Solutions

■ 16:10-16:30 Tea Break

■ 16：30-16：50

Keynote Speech 2 |Progress and Trends in the CGT Industry from an Investment Perspective

• Finance as a Tool: Understanding Capital Market Trends

• Industry as the Foundation: Current Status and Outlook of the CGT Sector

■ 16：50-17：10

Keynote Speech 3 |Southeast Asia Expansion Strategies for Innovative Pharmaceutical Companies

• Southeast Asia Expansion Strategies for Innovative Pharmaceutical Companies

• Specific Opportunities in Southeast Asia

• Drug Registration and Filing in Islamic Regions

• Overseas Collaboration Cases

■ 17：10-18：10

Panel 3 | Under the New Landscape, How Can CGT Companies Effectively “Raise and Spend Capital”?

• Say Goodbye to Cookie-Cutter Roadshows, Embrace Random Conversations

• Insights and Perspectives: Helping Enterprises Demonstrate Value

• "Prepare," Respect Uncertainty

• Innovative One-to-Many Interview-Style Project Pitch

■ 18:30–20:30 Dinner Reception

Event Scale: 50 people/session

Event Collaboration:

Ms. Fu 17851017836 (WeChat ID same as phone number)

Event Registration:

Capillaries 17782369627 (WeChat ID same as phone number)

Scan the QR code to register